Business Segments · Cost of Sales

Europe — Cost of Sales

Edwards Lifesciences Europe — Cost of Sales increased by 3.2% to $93.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $82.20M to $93.60M. Over 3 years (FY 2022 to FY 2025), Europe — Cost of Sales shows an upward trend with a 12.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026

How to read this metric

An increase relative to sales may indicate rising manufacturing costs or supply chain inefficiencies, while a decrease suggests improved production margins.

Detailed definition

This metric captures the direct costs associated with manufacturing and delivering medical devices sold within the Europ...

Peer comparison

Comparable to regional cost of goods sold (COGS) reported by peers in the medical technology sector.

Metric ID: ew_segment_europe_cost_of_sales

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$59.48M$59.48M$59.48M$59.48M$67.13M$67.13M$67.13M$67.13M$73.60M$74.40M$72.70M$78.40M$82.20M$84.80M$82.40M$90.70M$93.60M
QoQ Change+0.0%+0.0%+0.0%+12.9%+0.0%+0.0%+0.0%+9.6%+1.1%-2.3%+7.8%+4.8%+3.2%-2.8%+10.1%+3.2%
YoY Change+12.9%+12.9%+12.9%+12.9%+9.6%+10.8%+8.3%+16.8%+11.7%+14.0%+13.3%+15.7%+13.9%
Range$59.48M$93.60M
CAGR+12.0%
Avg YoY Growth+12.7%
Median YoY Growth+12.9%
Current Streak2 quarters growth

Frequently Asked Questions

What is Edwards Lifesciences's europe — cost of sales?
Edwards Lifesciences (EW) reported europe — cost of sales of $93.60M in Q1 2026.
How has Edwards Lifesciences's europe — cost of sales changed year-over-year?
Edwards Lifesciences's europe — cost of sales increased by 13.9% year-over-year, from $82.20M to $93.60M.
What is the long-term trend for Edwards Lifesciences's europe — cost of sales?
Over 3 years (2022 to 2025), Edwards Lifesciences's europe — cost of sales has grown at a 12.7% compound annual growth rate (CAGR), from $237.90M to $340.10M.
What does europe — cost of sales mean?
The direct costs incurred to produce and deliver products sold in Europe.